Tirzepatide 30mg — Lot COA, Canada
Research use only. Not for human or veterinary use.
Specifications
- form
- Lyophilized powder
- purity
- ≥99% (COA verified)
- use
- Research use only
Identity and purity numbers are the figures on the lot file, not a sitewide guarantee.
Documentation (HPLC / UPLC, MS, COA)
Published lots for this SKU are listed at the exact certificate section. Identity is typically confirmed by mass spectrometry; purity by HPLC / UPLC. A report for another peptide or fill size does not document this vial.
Research context
Tirzepatide 30mg is the black-cap research peptide fill. The published mass and endotoxin reports name this 30mg sample. A 10mg yellow-cap file does not document this vial. Research-use only.
🧬 Tirzepatide Peptide (30 mg)
Dual GIP / GLP‑1 Receptor Agonist for Advanced Metabolic Research in Canada
Tirzepatide peptide is a synthetic dual‑agonist research compound studied in laboratory settings for its interaction with GIP (glucose‑dependent insulinotropic polypeptide) and GLP‑1 (glucagon‑like peptide‑1) receptor pathways. Its unique ability to engage two incretin receptor systems simultaneously makes it a valuable tool in advanced metabolic and signaling research.
Supplied by BlueNexLabs, Tirzepatide is provided as a lyophilized research peptide (30 mg) with COA‑verified purity, optimized for Canadian research laboratories requiring audit‑safe RUO reagents.
🔬 Overview of Tirzepatide in Research Settings
Tirzepatide is designed as a synthetic peptide analog that enables controlled investigation of multi‑receptor incretin signaling in in‑vitro and preclinical research models. By activating both GIPR and GLP‑1R, it supports experimental exploration of how coordinated receptor engagement influences:
- Metabolic signal integration
- Energy‑regulation pathways
- Receptor bias and signaling efficiency
- Peptide structure–function relationships
Because of its dual‑agonist architecture, Tirzepatide is frequently used as a model compound in studies examining multi‑pathway peptide mechanisms and receptor crosstalk.
🧪 Research Applications (Non‑Medical)
Tirzepatide is intended strictly for laboratory research use and is commonly applied in:
- Dual‑receptor binding studies
- cAMP & intracellular signaling assays
- Peptide–receptor kinetics research
- Structure–function & stability studies
- Analytical & method development
All applications remain non‑clinical and research‑only.
🧬 Molecular & Chemical Characteristics
Type: Synthetic dual‑agonist peptide (GIPR + GLP‑1R)
Form: Lyophilized peptide powder
Size: 30 mg vial
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC
Structural Features
- Sequence‑level substitutions designed to improve enzymatic stability
- Fatty‑acid side chain enabling albumin interaction in vitro
- Demonstrates dual‑receptor engagement with measurable receptor bias
Biochemical Behavior
- Solubility dependent on pH, buffer system, and ionic strength
- Lipidated peptides may aggregate if improperly prepared
- Sensitive to oxidation and hydrolysis post‑reconstitution
❄️ Storage & Handling Guidelines
- Store lyophilized peptide at –20 °C, protected from light and moisture
- Reconstituted solutions: 2–8 °C, short‑term research use only
- Avoid repeated freeze–thaw cycles
- Aliquot after reconstitution if required
- Use low‑binding laboratory consumables to reduce peptide adsorption
📄 Certificate of Analysis (COA) & Documentation
Each batch of Tirzepatide supplied by BlueNexLabs includes audit‑ready documentation, consisting of:
- MS identity confirmation
- HPLC / UPLC purity results
- Solvent system disclosure
- Lot & batch traceability
🔗 View Certificate of Analysis (COA)
🔗Learn About Our Testing Standards
Learn about documentation standards in the FAQ
The black-cap 30 mg mass and endotoxin reports are in the Tirzepatide 30 mg certificate section. Those files do not document the Tirzepatide 10 mg yellow-cap vial. Tirzepatide lots are research-use only. Confirm the vial size on the Certificate of Analysis; a 30 mg report does not document a 10 mg fill.
Compliance Notice
Research-use only. Not for human or veterinary use. No medical, cosmetic, or performance claims are made or implied.
Canada fulfilment
- Ships inside Canada only on Canada Post Xpresspost after Interac e-Transfer. The standard rate is $25.00 CAD and is waived at a $299.00 product subtotal.
- Weekday cutoff: Canada Post does not operate on weekends or statutory holidays, so a Friday payment can wait until the next operating day for the first scan.
- Tracking is emailed after that scan, typically within one business day of payment. Estimates are not guarantees.
- The public desk is 4309 Canada Way, Burnaby, BC V5G 1J3. Labels use a Port Moody, B.C. PO Box. Provincial fulfilment FAQ.
Questions about laboratory procurement? Contact BlueNex Labs.
Research-use only. Not for human or veterinary use. BlueNex Labs does not provide administration guidance.
Questions about this listing
How do I match a tirzepatide 30 mg lot to its Certificate of Analysis?
This shop URL is the 30 mg black-cap fill. Open /certificates#tirzepatide-30mg and follow the mass and endotoxin links. The 10 mg yellow-cap listing is /shop/tirzepatide-10mg. A 30 mg file does not document a 10 mg vial.
What does research-use-only mean on the tirzepatide 30 mg listing?
Tirzepatide 30 mg is sold for laboratory work. It is not a medicine, food, cosmetic, or veterinary product. Research-use-only labeling is not a Health Canada authorization. Authorized drugs in Canada carry a Drug Identification Number.
How is tirzepatide 30 mg shipped and paid for in Canada?
Paid orders ship on Canada Post Xpresspost inside Canada after Interac e-Transfer to BlueNexLabs@gmail.com. Put the order number in the Interac message field. The standard rate is $25.00 CAD and is waived at $299.00 product subtotal. The public desk is 4309 Canada Way, Burnaby, BC V5G 1J3. Labels use a Port Moody, B.C. PO Box. The catalog does not ship outside Canada.
Where are storage notes for a tirzepatide 30 mg vial?
Tirzepatide 30 mg arrives as a lyophilized research solid. Move the sealed vial into controlled storage the same day. Receiving notes are on /research/peptide-storage-handling-guide-canada. That page does not set a solvent volume. Write 30 mg and black cap on the receiving line before you attach a report.